A Study of miRNA 371 in Patients With Germ Cell Tumors
Study Number: S1823
This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.
- Navigator Carrie, 309-243-3621 firstname.lastname@example.org
- Drea, 309-243-3626 email@example.com